Cowen and Company’s Zimmer Biomet ZBH Stock Holding History

Cowen and Company’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,632	Closed	-$380K	–	738
2022 Q3	$380K	Buy	+3,632	New	+$399K	0.04%	137
2022 Q2	–	Sell	-3,727	Closed	-$477K	–	766
2022 Q1	$477K	Sell	3,727 -4,832	-56%	-$582K	0.05%	165
2021 Q4	$1.06M	Buy	+8,559	New	+$1.12M	0.1%	161

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Cowen and Company's ZBH Position: Q4 2022 in Review

Cowen and Company sold out of Zimmer Biomet (ZBH) in Q4 2022, closing a stake of 3,632 shares — an estimated $380K sold.

Cowen and Company first reported a position in ZBH in Q4 2021 and held it in 3 quarters. The position peaked at $1.06M in Q4 2021. 977 funds tracked by Wall St. Rank hold ZBH as of Q4 2022.

Cowen and Company reported no remaining Zimmer Biomet position as of Q4 2022 after selling out during the quarter.
Cowen and Company sold 3,632 Zimmer Biomet shares in Q4 2022, an estimated $380K.
Cowen and Company first reported a position in Zimmer Biomet in Q4 2021 and held it in 3 quarters.
Cowen and Company's Zimmer Biomet position peaked at $1.06M in Q4 2021.
977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2022.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.